ADHERE Trial: Strategies to Improve Mobile App Adherence
ADHERE
Assisting Digital HEalth REtention (ADHERE Trial): Protocol for a Study Within a Trial (SWAT)
1 other identifier
interventional
258
1 country
1
Brief Summary
This study aims to evaluate the effectiveness of two communication interventions, compared to standard app notifications, in increasing adherence to a mobile health app among individuals with chronic low back pain. The main question it aims to answer is: Do phone calls or text messages increase adherence compared to app notifications in patients receiving a digital health intervention for chronic back pain? Participants will: A) Receive pain education and clinical hypnosis via a mobile app for managing chronic LBP; B) Will be contacted up to twice via phone call or text message, or they will only receive standard notifications from the app.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable low-back-pain
Started Oct 2025
Longer than P75 for not_applicable low-back-pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 25, 2025
CompletedFirst Posted
Study publicly available on registry
October 3, 2025
CompletedStudy Start
First participant enrolled
October 30, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 26, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
May 26, 2028
January 14, 2026
January 1, 2026
1.6 years
September 25, 2025
January 12, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Number of sessions completed
Mean difference of the number of sessions completed over 8 weeks between groups.
Week 8 post-randomisation
Secondary Outcomes (4)
Adherence rate (completer vs. non-completer)
Week 8 post-randomisation
Missing follow-up rate
Week 8 post-randomisation
Withdrawal rate
Week 8 post-randomisation
Cost-effectiveness
Week 8 post-randomisation
Study Arms (3)
App notifications
ACTIVE COMPARATORParticipants will receive the standard app notifications. Reminders are automatically sent at 8pm each day. A user can change the time of their reminder or turn off reminders in the app. The purpose of the app notifications is to increase motivation to complete the app sessions. An example app notification is: Your path to pain management is just a session away. Have you listened today?
Phone calls
EXPERIMENTALParticipants will receive standard app notifications, and if they do not engage with the intervention for more than three consecutive days , they will be contacted for adherence with up to two phone calls or voice messages, one week apart. The purpose of these calls will be to increase motivation and assess whether participants are experiencing any difficulties using the app or completing the sessions. We expect the calls to last no longer than five minutes. The phone call will include the following communication: Hi \[Name\], it's \[Researcher\] from Neuroscience Research Australia calling about the NOTUS back pain trial. I saw that you've done a few sessions on the NOTUS app - great job! We haven't seen you in the Relio app lately, so I wanted to check in and see if everything is working okay or if you need any help with anything. We look forward to seeing you back on the app as you continue retraining your pain system.
Text messages
EXPERIMENTALParticipants will receive the standard app notifications, and if they do not engage with the intervention for more than three consecutive days , they will be contacted for adherence with up to two SMS reminders, one week apart. The purpose of these SMS will be to increase motivation and assess whether participants are experiencing any difficulties using the app or completing the sessions. The text messages will include the following: Hey \[Name\], this is \[Researcher\] from Neuroscience Research Australia. I saw that you've done a few sessions on the NOTUS app - great job! We haven't seen you in the Relio app lately, so I wanted to check in and see if everything is working okay or if you need any help with anything. We look forward to seeing you back on the app as you continue retraining your pain system.
Interventions
Participants will receive standard app notifications and be contacted for adherence via two phone calls, a week apart, if they fail to engage with the intervention for more than three consecutive days. The purpose of these calls will be to assess whether participants are experiencing any difficulties using the app or completing the sessions.
Participants will receive the standard app notifications and receive a maximum of 2 text messages (SMS) a week apart, if they fail to engage with the intervention for more than three consecutive days.
Participants will receive the standard app notifications .
Eligibility Criteria
You may qualify if:
- Experiencing non-specific chronic low back pain (LBP), defined as pain between the 12th rib and the buttock crease.
- LBP with or without leg pain (in case of leg pain, LBP is worse than leg pain).
- Currently consulting with a general practitioner for their non-specific chronic LBP across Australia.
- Mean pain intensity score on the Numeric Rating Scale ≥ 3/10 in the past week.
- A score of at least moderate on question 8 of the physical functioning component of the SF-36 questionnaire.
- Access to a mobile device with minimal requirements to download the study app (300MB).
- An internet connection to access the mobile app functionalities.
- Able to understand English via reading and audio materials.
- Randomised to experimental group at NOTUS Trial.
You may not qualify if:
- Known or suspected specific spinal (e.g., radiculopathy, fracture) or specific non-spinal non- (e.g., tumour, infection) pathology.
- Less than six months post-spinal surgery.
- Scheduled for major surgery during the program or the follow-up period.
- Known or suspected serious psychiatric condition not being treated by a health professional that would impact adherence to the trial activities.
- Known or suspected sight or hearing problems that would limit access to the intervention components (reading and listening using headphones).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Neuroscience Research Australia
Sydney, New South Wales, 2031, Australia
Related Links
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
- Related Info
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- General practitioners and statisticians will be blind to group allocation. Blinding will be maintained for the entire duration of the trial until all data have been collected, and data analysis and interpretation have been completed. The personnel involved in the daily operations of the trial (e.g., research assistants and investigators who will provide possible technical support to participants and trial managers) will be unblinded to group allocation and will not be involved in the analyses.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 25, 2025
First Posted
October 3, 2025
Study Start
October 30, 2025
Primary Completion (Estimated)
May 26, 2027
Study Completion (Estimated)
May 26, 2028
Last Updated
January 14, 2026
Record last verified: 2026-01
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ANALYTIC CODE
- Time Frame
- Data will be made available after the publication of the study reports. There is no end date for the availability of study data.
De-identified individual participant data will be made available to interested researchers only upon reasonable request and once the proposed research project has received separate ethics approval from a Human Research Ethics Committee. Request to the data custodian, the Principal Investigator (j.mcauley@neura.edu.au).